Better Care for PFAS Patients Act of 2026
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- Senate
- Sponsors
- 2
- Latest action
- Jan 8, 2026
What it does
The Better Care for PFAS Patients Act of 2026 would require the Director of the Agency for Toxic Substances and Disease Registry to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine (or another appropriate entity) to periodically assess the health effects of PFAS measurable in human tissues and formulate clinical recommendations. The initial assessment and recommendations must be completed within two years of the agreement, with updates required at least every five years or more frequently if warranted by new science. Based on these assessments, the Director must issue, post, and disseminate up-to-date clinical guidance on addressing PFAS health…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.